Niagen Bioscience (NAGE) vs Trulieve Cannabis Subordinate Voting Shares (TRLV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Trulieve Cannabis Subordinate Voting Shares (TRLV) has outperformed Niagen Bioscience (NAGE) over the past year, gaining 18.0% versus a loss of 64.2%. Over five years, NAGE leads with a -58.2% price change compared with -60.5% for TRLV. Trulieve Cannabis Subordinate Voting Shares is the larger company by market cap ($2.00 billion vs $210.5 million), about 9.5 times the size.
On valuation, Trulieve Cannabis Subordinate Voting Shares trades at a lower forward P/E (18.6x vs 26.6x for Niagen Bioscience).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NAGE | TRLV |
|---|---|---|
| Share price | $2.66 | $10.37 |
| Market cap | $210.48M | $2.00B |
| 1-day change | -2.21% | -3.80% |
| YTD return | -58.18% | +19.33% |
| 1-year return | -64.20% | +17.97% |
| 5-year return | -58.18% | -60.45% |
| P/E ratio (TTM) | 14.00 | — |
| Forward P/E | 26.60 | 18.63 |
| EPS (TTM) | $0.19 | $-2.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.95 | $13.28 |
| 52-week low | $2.61 | $4.62 |
| Distance from 52-week high | -66.54% | -21.91% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +354.14% | +75.31% |
| Average volume | 585.78K | 1.60M |
| Shares outstanding | 79.13M | 170.16M |
| Employees | 117 | 5,000 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Trulieve Cannabis Subordinate Voting Shares is about 9.5 times larger than Niagen Bioscience by market value ($2.00B vs $210.48M).
- TRLV has outperformed NAGE by 82.2 percentage points over the past year.
About Niagen Bioscience
NAGE stock →Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products.
Health Care · Medicinal Chemicals and Botanical Products · 117 employees
About Trulieve Cannabis Subordinate Voting Shares
TRLV stock →Trulieve Cannabis Corp. operates as a cannabis retailer in the United States.
Health Care · Medicinal Chemicals and Botanical Products · 5,000 employees
NAGE vs TRLV FAQ
Which is bigger, Niagen Bioscience or Trulieve Cannabis Subordinate Voting Shares?
Trulieve Cannabis Subordinate Voting Shares (TRLV) is larger, with a market capitalization of $2.00B compared with $210.48M for Niagen Bioscience (NAGE).
Which stock has performed better over the past year, NAGE or TRLV?
TRLV returned +17.97% over the past 12 months, compared with -64.20% for NAGE (price return, excluding dividends). Past performance does not predict future results.
Are Niagen Bioscience and Trulieve Cannabis Subordinate Voting Shares in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.